Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154492 | PMC |
| http://dx.doi.org/10.1038/mt.2016.196 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Developing adenoviral vectors encoding therapeutic genes toxic to host cells: Comparing binary and single-inducible vectors expressing truncated E2F-1" [Virology 397 (2010) 337-345].
Virology
December 2024
The Hiram C. Polk Jr., M.D., Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40292, USA. Electronic address:
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
Int J Oncol
November 2024
Genitourinary Oncology Research Laboratory, Department of Medicine, Weill Cornell Medical College and Weill Cornell Cancer Center, New York, NY 10021, USA.
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the immunostaining experiments shown in Fig. 3C on p. 1195, the 'NEP' and 'PTX' panels contained overlapping data, such that data which were intended to show the results of differently performed experiments had apparently been derived from the same original source.
View Article and Find Full Text PDFCorrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes.
Front Immunol
February 2023
McMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research, Hamilton, ON, Canada.
[This corrects the article DOI: 10.3389/fimmu.2022.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!